Top

International Archives of Occupational and Environmental Health

Published in:

01-07-2007 | Short Communication

Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study

Authors: O. Midasch, H. Drexler, N. Hart, M. W. Beckmann, J. Angerer

Published in: International Archives of Occupational and Environmental Health | Issue 7/2007

Abstract

Objectives

Perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) can be released of perfluorinated compounds by biotic and/or metabolic decomposition. Due to their ubiquitous occurrence, persistence and bioaccumulative properties they can be found in blood of the general population all over the world. In animal studies PFOS and PFOA provoked cancer and showed developmental toxic potential besides other adverse health effects. On the basis of the comparison of maternal and umbilical cord plasma sample pairs we wanted to examine whether infants are exposed to PFOS and PFOA via their mothers’ blood.

Methods

We determined PFOS and PFOA in 11 plasma samples of mothers and the 11 corresponding cord plasma samples of neonates. An analytical method based on plasma protein precipitation followed by HPLC with MS/MS-detection was employed. As internal standards we used 1,2,3,4-¹³C₄-PFOS and 1,2-¹³C₂-PFOA.

Results

We found PFOS and PFOA in every plasma sample analysed. In maternal plasma samples PFOS concentrations were consistently higher compared to those of the related cord plasma samples (median: 13.0 μg/l vs. 7.3 μg/l). In the case of PFOA we observed only minor differences between PFOA concentrations within the analysed sample pairs (median: 2.6 μg/l vs. 3.4 μg/l for maternal and cord plasma samples, respectively).

Discussion

For both substances a crossing of the placental barrier could be shown. For PFOS we observed a decrease from maternal to cord plasma concentrations by a factor of 0.41–0.80. To the contrary, PFOA crosses the placental barrier obviously unhindered. These findings show that neonates are exposed to PFOS and PFOA via their mothers’ blood. Given the current situation that only little is known about the consequences of PFOS and PFOA exposure in the early state of development of humans and the fact that in animal studies both substances showed developmental toxic effects further research regarding human health effects is indispensable.

3M (2002) 104-week dietary chronic toxicity and carcinogenicity study with perfluorooctane sulfonic acid potassium salt (PFOS; T-6295) in rats. Final Report. 3M T-6295 (Covance study no: 6329-183), vol I-IX , 4068 pages, 3M, St Paul, Minnesota

Butenhoff JL, Kennedy GL Jr, Frame SR, O’Connor JC, York RG (2004) The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196(1–2):95–116PubMedCrossRef

Butenhoff JL, York R, Seacat A, Luebker D (2002) Perfluorooctanesulfonate induced perinatal mortality in rat pups is associated with a steep dose-response. Toxicologist 66:25

Calafat AM, Needham LL, Kuklenyik Z, Reidy JA, Tully JS, Aguilar-Villalobos M, Naeher LP (2005) Perfluorinated chemicals in selected residents of the American continent. Chemosphere 63(3):490–496PubMedCrossRef

Christian MS, Hoberman AM, York RG (1999) Combined oral (gavage) fertility, developmental and perinatal/postnatal reproduction toxicity study of PFOS in rats. Argus Research Laboratories Inc., Horsham, PA US EPA Docket 8EHQ-0200–00374

Cochran TE, Good W (1974) The distribution of immunoglobulins and albumin between maternal and cord serum at delivery. J Obstet Gynaecol Br Commonw 81:980–987

Dinglasan MJ, Ye Y, Edwards EA, Mabury SA (2004) Fluorotelomer alcohol biodegradation yields poly- and perfluorinated acids. Environ Sci Technol 38(10):2857–2864PubMed

Ellis DA, Martin JW, De Silva AO, Mabury SA, Hurley MD, Sulbaek Andersen MP, Wallington TJ (2004) Degradation of fluorotelomer alcohols: a likely atmospheric source of perfluorinated carboxylic acids. Environ Sci Technol 38(12):3316–3321PubMedCrossRef

Fromme H, Midasch O, Twardella D, Angerer J, Boehmer S, Liebl B (2006) Occurrence of perfluorinated substances in an adult German population in southern Bavaria. Int Arch Occup Environ Health (in press)

Gauthier SA, Mabury SA (2005) Aqueous photolysis of 8:2 fluorotelomer alcohol. Environ Toxicol Chem 24(8):1837–1846PubMedCrossRef

Giesy JP, Kannan K (2001) Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 35(7):1339–1342PubMedCrossRef

Giesy JP, Kannan K (2002) Perfluorochemical surfactants in the environment. Environ Sci Technol 36(7):146A–152APubMed

Grasty RC, Bjork JA, Wallace KB, Lau CS, Rogers JM (2005) Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res B Dev Reprod Toxicol 74(5):405–416PubMedCrossRef

Grasty RC, Grey BE, Lau CS, Rogers JM (2003) Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B Dev Reprod Toxicol 68(6):465–471PubMedCrossRef

Guruge KS, Taniyasu S, Yamashita N, Wijeratna S, Mohotti KM, Seneviratne HR, Kannan K, Yamanaka N, Miyazaki S (2005) Perfluorinated organic compounds in human blood serum and seminal plasma: a study of urban and rural tea worker populations in Sri Lanka. J Environ Monit 7(4):371–377PubMedCrossRef

Han X, Snow TA, Kemper RA, Jepson GW (2003) Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol 16(6):775–781PubMed

Harada K, Saito N, Inoue K, Yoshinaga T, Watanabe T, Sasaki S, Kamiyama S, Koizumi A (2004) The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years. J Occup Health 46(2):141–147PubMedCrossRef

Hill MD, Abramson FP (1988) The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state. Clin Pharmacokinet 14(3):156–170PubMedCrossRef

Hinderliter PM, Mylchreest E, Gannon SA, Butenhoff JL, Kennedy GL Jr (2005) Perfluorooctanoate: placental and lactational transport pharmacokinetics in rats. Toxicology 211(1–2):139–148PubMedCrossRef

Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, Uno A, Saijo Y, Sata F, Yoshimura Y, Kishi R, Nakazawa H (2004) Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112(11):1204–1207PubMedCrossRef

Jin Y, Liu X, Li T, Qin H (2004) Status of perfluorochemicals in adult serum and umbilical blood in Shenyang. Wei Sheng Yan Jiu 33(4):481–483PubMed

Kannan K, Corsolini S, Falandysz J, Fillmann G, Kumar KS, Loganathan BG, Mohd MA, Olivero J, Van Wouwe N, Yang JH, Aldoust KM (2004) Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 38(17):4489–4495PubMedCrossRef

Kannan K, Koistinen J, Beckmen K, Evans T, Gorzelany JF, Hansen KJ, Jones PD, Helle E, Nyman M, Giesy JP (2001) Accumulation of perfluorooctane sulfonate in marine mammals. Environ Sci Technol 35(8):1593–1598PubMedCrossRef

Kärrman A (2004) Perfluoroalkylated compounds in whole blood and plasma from the Swedish population. Organohalogen Compd 66:4058–4062

Krauer B, Dayer P, Anner R (1984) Changes in serum albumin and alpha 1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs. Br J Obstet Gynaecol 91(9):875–881PubMed

Kubwabo C, Vais N, Benoit FM (2004) A pilot study on the determination of perfluorooctanesulfonate and other perfluorinated compounds in blood of Canadians. J Environ Monit 6(6):540–545PubMedCrossRef

Kuklenyik Z, Reich JA, Tully JS, Needham LL, Calafat AM (2004) Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. Environ Sci Technol 38(13):3698–3704PubMedCrossRef

Lau C, Butenhoff JL, Rogers JM (2004) The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198(2):231–241PubMedCrossRef

Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, Strynar MJ (2006) Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90(2):510–518PubMedCrossRef

Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA (2003) Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 74(2):382–392PubMedCrossRef

Luebker DJ, Case MT, York RG, Moore JA, Hansen KJ, Butenhoff JL (2005a) Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 215(1–2):126–148CrossRef

Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL (2005b) Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 215(1–2):149–169CrossRef

Martin JW, Mabury SA, O’Brien PJ (2005) Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes. Chem Biol Interact 155(3):165–180PubMedCrossRef

Midasch O, Schettgen T, Angerer J (2006) Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population. Int J Hyg Environ Health 209(6):489–496PubMedCrossRef

OECD (2002) Hazard assessment of perfluorooctane sulfonate (PFOS) and its salts. ENV/JM/RD(2002)17/FINAL

Olsen G, Ehresman D, Froehlich J, Burris J, Butenhoff J (2005) Evaluation of the half-life (t1/2) of elimination of perfluorooctanesulfonate (PFOS), perfluorohexanesulfonate (PFHS) and perfluorooctanoate (PFOA) from human serum. Presentation at the 9th FLUOROS, International symposium on fluorinated alkyl organics in the environment, Toronto, Canada, Abstract book available at: http://www.chem.utoronto.ca/symposium/fluoros/Flourosabstractbook.pdf

Olsen GW, Church TR, Larson EB, van Belle G, Lundberg JK, Hansen KJ, Burris JM, Mandel JH, Zobel LR (2004) Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. Chemosphere 54(11):1599–1611PubMedCrossRef

Olsen GW, Church TR, Miller JP, Burris JM, Hansen KJ, Lundberg JK, Armitage JB, Herron RM, Medhdizadehkashi Z, Nobiletti JB, O’Neill EM, Mandel JH, Zobel LR (2003a) Perfluorooctanesulfonate and other fluorochemicals in the serum of American red cross adult blood donors. Environ Health Perspect 111(16):1892–1901CrossRef

Olsen GW, Hansen KJ, Stevenson LA, Burris JM, Mandel JH (2003b) Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. Environ Sci Technol 37(5):888–891CrossRef

Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C (2003) Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci 74(2):369–381PubMedCrossRef

UBA (2004) Untersuchung archivierter Proben der Umweltprobenbank des Bundes auf perfluorierte organische Verbindungen. Cited in: http://www.bmu.de/files/chemikalien/downloads/application/pdf/artikel_perfluortensiden.pdf

US EPA (2003) Preliminary risk assessment of the developmental toxicity associated with exposure to perfluorooctanoic acid and its salts. US EPA, OPPT-2003–0012; FRL-7303–8

US EPA (2005) Draft risk assessment of the potential human health effects associated with exposure to perfluorooctanoic acid and its salts. Available at http://www.epa.gov/opptintr/pfoa/pubs/pfoarisk.pdf

Wallington TJ, Hurley MD, Xia J, Wuebbles DJ, Sillman S, Ito A, Penner JE, Ellis DA, Martin J, Mabury SA, Nielsen OJ, Sulbaek Andersen MP (2006) Formation of C7F15COOH (PFOA) and other perfluorocarboxylic acids during the atmospheric oxidation of 8:2 fluorotelomer alcohol. Environ Sci Technol 40(3):924–930PubMedCrossRef

Xu L, Krenitsky DM, Seacat AM, Butenhoff JL, Anders MW (2004) Biotransformation of N-ethyl-N-(2-hydroxyethyl) perfluorooctanesulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450. Chem Res Toxicol 17(6):767–775PubMedCrossRef

Yeung LW, So MK, Jiang G, Taniyasu S, Yamashita N, Song M, Wu Y, Li J, Giesy JP, Guruge KS, Lam PK (2006) Perfluorooctanesulfonate and related fluorochemicals in human blood samples from China. Environ Sci Technol 40(3):715–720PubMedCrossRef

Title: Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study
Authors: O. Midasch
H. Drexler
N. Hart
M. W. Beckmann
J. Angerer
Publication date: 01-07-2007
Publisher: Springer-Verlag
Published in: International Archives of Occupational and Environmental Health / Issue 7/2007
Print ISSN: 0340-0131
Electronic ISSN: 1432-1246
DOI: https://doi.org/10.1007/s00420-006-0165-9

At a glance: The STEP trials

Springer Medicine

Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study

Abstract

Objectives

Methods

Results

Discussion

At a glance: The STEP trials

Springer Medicine

Abstract

Objectives

Methods

Results

Discussion

Please log in to get access to this content

Other articles of this Issue 7/2007

Workdays, in-between workdays and the weekend: a diary study on effort and recovery

Levels of 2-thiothiazolidine-4-carboxylic acid (TTCA) and effect modification of polymorphisms of glutathione-related genes in vulcanization workers in the southern Sweden rubber industries

Airflow limitation among workers in a labour-intensive coal mine in Tanzania

The impact of major heat waves on all-cause and cause-specific mortality in France from 1971 to 2003

Fatigue, emotional exhaustion and perceived health complaints associated with work-related characteristics in employees with and without chronic diseases

Elimination kinetics of metals after an accidental exposure to welding fumes